@BristolBRC @ProfJonIves @CSR_Bris @BlazebyJ @BristolEthics @ProfRHuxtable @YellowBicyclist @TheOrganOgress So interesting and I couldn’t agree more. I’ll be sure to read the paper. See also NICE’s constant reference to “innovative” (i.e. often unproven, o
@NarcyzGhinea Thanks. It’s part of an ongoing PhD project so only a couple of papers so far, but I’m hoping to publish a follow-up to the NICE and Fair piece in the next few months and you might find this interesting https://t.co/LmioJBdxLf
RT @VicCharlton: Excited to be presenting our work on innovation as a social value at #ASBH19. Hoping for some input on the possible ethica…
Excited to be presenting our work on innovation as a social value at #ASBH19. Hoping for some input on the possible ethical justifications for paying a premium for highly innovative treatments. #HTA #prioritysetting https://t.co/LmioJBdxLf
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
RT @VicCharlton: @JamesLomas88 Quite. And that’s without paying an additional premium for other factors like end-of-life or ‘innovative’ tr…
@JamesLomas88 Quite. And that’s without paying an additional premium for other factors like end-of-life or ‘innovative’ treatments. IMHO these become increasingly difficult to justify in this context. See https://t.co/LmioJBdxLf
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
RT @felly500: "Our findings fail to assuage pre-existing concerns that NICE’s approach to appraising innovative technologies curtails its g…
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
"Our findings fail to assuage pre-existing concerns that NICE’s approach to appraising innovative technologies curtails its goals to promote health and health equity" Back to parks vs cancer drugs Or cath labs and cardio gizmos v bike lanes?? Cc @DrChris
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
Indeed...
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
RT @kchalkidou: NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
NICE's runaway threshold...https://t.co/5IdWtKYMDx https://t.co/KWRXS1MCfv
RT @pash22: Innovation as a value in healthcare priority-setting: the UK experience https://t.co/mH6aY222Cd You will like this one, since y…
Innovation as a value in healthcare priority-setting: the UK experience https://t.co/mH6aY222Cd You will like this one, since you are a haemato-oncologist Bish @oncology_bg
@felly500 The innovation premium piece:
@catherine_max @anetrid Thanks Catherine. I see that CAR-T personalised therapy for blood cancer has also now been approved (at price unknown.) And the paper is indeed published: https://t.co/LmioJBdxLf
The new special issue of Social Justice Research is now available! Check out #OpenAccess article, "Innovation as a value in healthcare priority-setting: the UK experience" - https://t.co/oTyIlJuKpV
RT @NIHBioethics: Our Annette Rid has a new paper out in Social Justice Research on how efforts to promote healthcare innovation in the pri…
RT @NIHBioethics: Our Annette Rid has a new paper out in Social Justice Research on how efforts to promote healthcare innovation in the pri…
RT @NIHBioethics: Our Annette Rid has a new paper out in Social Justice Research on how efforts to promote healthcare innovation in the pri…
RT @NIHBioethics: Our Annette Rid has a new paper out in Social Justice Research on how efforts to promote healthcare innovation in the pri…
RT @NIHBioethics: Our Annette Rid has a new paper out in Social Justice Research on how efforts to promote healthcare innovation in the pri…
RT @NIHBioethics: Our Annette Rid has a new paper out in Social Justice Research on how efforts to promote healthcare innovation in the pri…
Our Annette Rid has a new paper out in Social Justice Research on how efforts to promote healthcare innovation in the priority-setting process can complicate trade-offs between maximizing health and promoting health equity. Read it here! https://t.co/UfV
RT @anetrid: New paper with the fabulous @VicCharlton @GHSMatKCL https://t.co/ulY5BE0fxu (OA) 1/3 https://t.co/bTOGmIHpIJ
RT @catherine_max: Important read on @NICEComms 'innovation premium', social value and equity by my fine colleagues @anetrid @VicCharlton.…
RT @cccoultas: @VicCharlton and @anetrid’s really important analysis showing how @NICEComms use of ‘innovation’ as a decision-making princi…
RT @cccoultas: @VicCharlton and @anetrid’s really important analysis showing how @NICEComms use of ‘innovation’ as a decision-making princi…
RT @albertpweale: This is a fine paper by @anetrid @VicCharlton on the problematic character of NICE adoption and use of 'innovation' as a…
Important read on @NICEComms 'innovation premium', social value and equity by my fine colleagues @anetrid @VicCharlton. One for @felly500 @RslewisSally @DrChrisGibbons @deb_cohen
RT @cccoultas: @VicCharlton and @anetrid’s really important analysis showing how @NICEComms use of ‘innovation’ as a decision-making princi…
RT @cccoultas: @VicCharlton and @anetrid’s really important analysis showing how @NICEComms use of ‘innovation’ as a decision-making princi…
RT @cccoultas: @VicCharlton and @anetrid’s really important analysis showing how @NICEComms use of ‘innovation’ as a decision-making princi…
@VicCharlton and @anetrid’s really important analysis showing how @NICEComms use of ‘innovation’ as a decision-making principle is compromising its goal of promoting health and health equity
RT @anetrid: New paper with the fabulous @VicCharlton @GHSMatKCL https://t.co/ulY5BE0fxu (OA) 1/3 https://t.co/bTOGmIHpIJ
RT @albertpweale: This is a fine paper by @anetrid @VicCharlton on the problematic character of NICE adoption and use of 'innovation' as a…
This is a fine paper by @anetrid @VicCharlton on the problematic character of NICE adoption and use of 'innovation' as a criterion of assessment. Hope it is widely read.
New paper with the fabulous @VicCharlton @GHSMatKCL https://t.co/ulY5BE0fxu (OA) 1/3 https://t.co/bTOGmIHpIJ
RT @VicCharlton: New paper by the fabulous @anetrid and I. Frequent #NICE use of “innovation” as justification for exceeding the cost-eff…
New paper by the fabulous @anetrid and I. Frequent #NICE use of “innovation” as justification for exceeding the cost-effectiveness threshold may be to the detriment of population health & health equity. #NHS #prioritysetting #bestPhDsupervisorever h